(18)F-FDG PET/CT findings in a case with HIV (-) Kaposi sarcoma

E Ozdemir; N Y Poyraz; M Keskin; Z Kandemir; S Turkolmez

doi:10.1016/j.remn.2013.08.003

(18)F-FDG PET/CT findings in a case with HIV (-) Kaposi sarcoma

Rev Esp Med Nucl Imagen Mol. 2014 May-Jun;33(3):175-7. doi: 10.1016/j.remn.2013.08.003. Epub 2013 Oct 10.

Authors

E Ozdemir¹, N Y Poyraz², M Keskin², Z Kandemir², S Turkolmez²

Affiliations

¹ Department of Nuclear Medicine, Ataturk Training and Research Hospital, Ankara, Turkey. Electronic address: ecingi@yahoo.com.
² Department of Nuclear Medicine, Ataturk Training and Research Hospital, Ankara, Turkey.

PMID: 24119549
DOI: 10.1016/j.remn.2013.08.003

Abstract

Although mucocutaneous sites are the most frequently encountered sites of involvement, Kaposi Sarcoma (KS) may also occasionally involve the breast and the skeletal, endocrine, urinary and nervous systems.. Various imaging modalities may be used to delineate the extent of the disease by detecting unexpected sites of involvement. Herein, we report a case of classical type KS, in whom staging with (18)F-FDG PET/CT imaging disclosed widespread disease and unexpected findings of bone and salivary gland involvement.

Keywords: (18)F-FDG PET/CT; (18)F-FDG PET/TC; Bone metastasis; Glándulas salivales; Kaposi Sarcoma; Metástasis ósea; Salivary glands; Sarcoma de Kaposi.

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Fluorodeoxyglucose F18*
HIV Seronegativity*
Humans
Male
Multimodal Imaging*
Positron-Emission Tomography*
Radiopharmaceuticals*
Sarcoma, Kaposi / diagnostic imaging*
Skin Neoplasms / diagnostic imaging*
Tomography, X-Ray Computed*

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18